↓ Skip to main content

Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome

Overview of attention for article published in Translational Neurodegeneration, November 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter
15 tweeters

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
64 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
Published in
Translational Neurodegeneration, November 2018
DOI 10.1186/s40035-018-0133-9
Pubmed ID
Authors

Antonella Tramutola, Chiara Lanzillotta, Eugenio Barone, Andrea Arena, Ilaria Zuliani, Luciana Mosca, Carla Blarzino, D. Allan Butterfield, Marzia Perluigi, Fabio Di Domenico

Twitter Demographics

The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 64 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 10 16%
Student > Ph. D. Student 10 16%
Student > Master 8 13%
Researcher 7 11%
Student > Doctoral Student 3 5%
Other 8 13%
Unknown 18 28%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 20%
Unspecified 9 14%
Neuroscience 8 13%
Medicine and Dentistry 5 8%
Psychology 2 3%
Other 7 11%
Unknown 20 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 June 2022.
All research outputs
#3,777,360
of 21,596,161 outputs
Outputs from Translational Neurodegeneration
#159
of 293 outputs
Outputs of similar age
#86,866
of 338,315 outputs
Outputs of similar age from Translational Neurodegeneration
#12
of 32 outputs
Altmetric has tracked 21,596,161 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 293 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.2. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 338,315 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.